Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Rubinstein-Taybi Syndrome: Functional Imaging and Therapeutic Trial (RUBIVAL)

This study has been completed.
Fondation Syndrome de Rubinstein-Taybi
Information provided by (Responsible Party):
University Hospital, Bordeaux Identifier:
First received: June 12, 2012
Last updated: March 17, 2015
Last verified: March 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2014
  Primary Completion Date: September 2014 (Final data collection date for primary outcome measure)